← Open Payments lookup

ALYSSA LOFTUS: Open Payments

NPI 1346894623 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,041 in 44 payments from 14 companies in 2025. Trend: 2023 $1,047 · 2024 $1,041 · 2025 $1,041

Food & beverage: $1,041
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$160
Alkermes, Inc.6$136
Neurocrine BioSciences, Inc.5$120
E.R. Squibb & Sons, L.L.C.4$117
Otsuka America Pharmaceutical, Inc.4$90
Lundbeck LLC3$83
Janssen Pharmaceuticals, Inc3$68
Axsome Therapeutics, Inc.3$65
Vanda Pharmaceuticals Inc.2$54
Corium, LLC3$48

Products named: REXULTI, CAPLYTA, INGREZZA, COBENFY, LYBALVI, Auvelity, ARISTADA, Azstarys.

Industry payments across PA — which companies pay providers there.